165 related articles for article (PubMed ID: 18227614)
21. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and Paratyphi A isolates with decreased susceptibility to ciprofloxacin.
Misra R; Thakare R; Amrin N; Prasad KN; Chopra S; Dhole TN
Trans R Soc Trop Med Hyg; 2016 Aug; 110(8):472-9. PubMed ID: 27618918
[TBL] [Abstract][Full Text] [Related]
22. Changing trends in the antibiograms of Salmonella isolates at a tertiary care hospital in Hyderabad.
Lakshmi V; Ashok R; Susmita J; Shailaja VV
Indian J Med Microbiol; 2006 Jan; 24(1):45-8. PubMed ID: 16505555
[TBL] [Abstract][Full Text] [Related]
23. Drug-resistant enteric fever in the UK.
Threlfall EJ; Day M; de Pinna E; Lewis H; Lawrence J
Lancet; 2006 May; 367(9522):1576. PubMed ID: 16698409
[No Abstract] [Full Text] [Related]
24. Changing Patterns in Enteric Fever Incidence and Increasing Antibiotic Resistance of Enteric Fever Isolates in the United States, 2008-2012.
Date KA; Newton AE; Medalla F; Blackstock A; Richardson L; McCullough A; Mintz ED; Mahon BE
Clin Infect Dis; 2016 Aug; 63(3):322-9. PubMed ID: 27090993
[TBL] [Abstract][Full Text] [Related]
25. Enteric fever caused by Salmonella isolates with decreased susceptibility to ciprofloxacin.
Karunanayake L; Atukorala SD
Ceylon Med J; 2004 Dec; 49(4):137-8. PubMed ID: 15693457
[TBL] [Abstract][Full Text] [Related]
26. Enteric fever.
Basnyat B; Qamar FN; Rupali P; Ahmed T; Parry CM
BMJ; 2021 Feb; 372():n437. PubMed ID: 33637488
[No Abstract] [Full Text] [Related]
27. Treatment Response in Enteric Fever in an Era of Increasing Antimicrobial Resistance: An Individual Patient Data Analysis of 2092 Participants Enrolled into 4 Randomized, Controlled Trials in Nepal.
Thompson CN; Karkey A; Dongol S; Arjyal A; Wolbers M; Darton T; Farrar JJ; Thwaites GE; Dolecek C; Basnyat B; Baker S
Clin Infect Dis; 2017 Jun; 64(11):1522-1531. PubMed ID: 28329181
[TBL] [Abstract][Full Text] [Related]
28. Azithromycin susceptibility among clinical isolates of Salmonella: Interfacing guidelines with routine practices.
Chatterjee S; Eshwara VK; Tellapragada C; Mukhopadhyay C
Indian J Med Microbiol; 2016; 34(3):397-8. PubMed ID: 27514976
[No Abstract] [Full Text] [Related]
29. Absence of multidrug resistance in Salmonella enterica serotypes Typhi and Paratyphi A isolates with intermediate susceptibility to ciprofloxacin.
Misra R; Prasad KN; Amrin N; Kapoor P; Singh S; Ghar M
Trans R Soc Trop Med Hyg; 2015 Aug; 109(8):538-40. PubMed ID: 25979527
[TBL] [Abstract][Full Text] [Related]
30. Burden of typhoid and paratyphoid fever in a densely populated urban community, Dhaka, Bangladesh.
Naheed A; Ram PK; Brooks WA; Hossain MA; Parsons MB; Talukder KA; Mintz E; Luby S; Breiman RF
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e93-9. PubMed ID: 20236850
[TBL] [Abstract][Full Text] [Related]
31. Multi-drug resistance in salmonellae isolated from enteric fever cases at Porur--a semi urban area near Madras City.
Verghese SL; Manonmani R; Balasubramanian S; Chandrasekharan S
J Commun Dis; 1992 Mar; 24(1):12-5. PubMed ID: 1296946
[TBL] [Abstract][Full Text] [Related]
32. Decreased ciprofloxacin susceptibility in Salmonella Typhi and Paratyphi infections in ill-returned travellers: the impact on clinical outcome and future treatment options.
Hassing RJ; Goessens WH; Mevius DJ; van Pelt W; Mouton JW; Verbon A; van Genderen PJ
Eur J Clin Microbiol Infect Dis; 2013 Oct; 32(10):1295-301. PubMed ID: 23609512
[TBL] [Abstract][Full Text] [Related]
33. Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Salmonella enterica serovars Typhi and Paratyphi.
Day MR; Doumith M; Do Nascimento V; Nair S; Ashton PM; Jenkins C; Dallman TJ; Stevens FJ; Freedman J; Hopkins KL; Woodford N; De Pinna EM; Godbole G
J Antimicrob Chemother; 2018 Feb; 73(2):365-372. PubMed ID: 29216342
[TBL] [Abstract][Full Text] [Related]
34. A comparative trial of furazolidone and chloramphenicol in typhoid and paratyphoid fever.
Salgado MR; Lionel ND
Ceylon Med J; 1970 Sep; 15(3):159-62. PubMed ID: 4995053
[No Abstract] [Full Text] [Related]
35. In vitro activity of azithromycin, newer quinolones and cephalosporins in ciprofloxacin-resistant Salmonella causing enteric fever.
Capoor MR; Rawat D; Nair D; Hasan AS; Deb M; Aggarwal P; Pillai P
J Med Microbiol; 2007 Nov; 56(Pt 11):1490-1494. PubMed ID: 17965350
[TBL] [Abstract][Full Text] [Related]
36. Resistance Patterns of Typhoid Fever in Children: A Longitudinal Community-Based Study.
Vala S; Shah U; Ahmad SA; Scolnik D; Glatstein M
Am J Ther; 2016; 23(5):e1151-4. PubMed ID: 24987946
[TBL] [Abstract][Full Text] [Related]
37. [A case of Salmonella enterica serovar typhi with decreased susceptibility to ciprofloxacin].
Gaborieau V; Weill FX; Marchou B
Med Mal Infect; 2010 Dec; 40(12):691-5. PubMed ID: 20724089
[TBL] [Abstract][Full Text] [Related]
38. Screening method for Salmonella enterica serovar Typhi and serovar Paratyphi A with reduced susceptibility to fluoroquinolones by PCR-restriction fragment length polymorphism.
Hirose K; Tamura K; Watanabe H
Microbiol Immunol; 2003; 47(2):161-5. PubMed ID: 12680720
[TBL] [Abstract][Full Text] [Related]
39. Ciprofloxacin resistance in Salmonella paratyphi A.
Brown NM; Millar MR; Frost JA; Rowe B
J Antimicrob Chemother; 1994 Jun; 33(6):1258-9. PubMed ID: 7928825
[No Abstract] [Full Text] [Related]
40. Ciprofloxacin treatment failure in a case of typhoid fever caused by Salmonella enterica serotype Paratyphi A with reduced susceptibility to ciprofloxacin.
Dimitrov T; Udo EE; Albaksami O; Kilani AA; Shehab EMR
J Med Microbiol; 2007 Feb; 56(Pt 2):277-279. PubMed ID: 17244813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
